Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Granisetron 3mg/3mL
Granisetron hydrochloride 1.12mg/mL equivalent to granisetron 1mg/mL
Solution for injection
Deva Holdings NZ Limited
Deva Holding AS, Kartepe, Turkey
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Ipca-Citalopram
Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Film coated tablet
Actavis New Zealand Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Ipca-Losartan
Losartan potassium 12.5mg
Film coated tablet
Actavis New Zealand Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Lumexia
Methyl aminolevulinate hydrochloride 200mg/g
equivalent to methyl aminolevulinate 160mg/g
Topical cream
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Penn Pharmaceutical Services Limited, Tredegar, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Sodium Chloride for Injection 0.9% w/v
Sodium chloride 0.9% w/v
Solution for injection
InterPharma (NZ) Limited
Amanta Healthcare Limited, Hariyala, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Water for Injections BP
Water for injection 100% v/v
Solution for injection
InterPharma (NZ) Limited
Amanta Healthcare Limited, Hariyala, India
|
Dated this 29th day of July 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz